Navigation Links
Fate Therapeutics Closes $30 Million Series B Financing
Date:11/16/2009

atment options."

Fate Therapeutics is developing its lead Stem Cell Modulator, FT1050, to enhance hematopoietic stem cell (HSC) proliferation and homing. The small molecule is currently undergoing clinical testing at the Dana Farber Cancer Institute and Massachusetts General Hospital in adult patients with hematologic malignancies, such as leukemia and lymphoma, who have undergone nonmyeloablative conditioning therapy and are in need of HSC support. The Phase 1b study is intended to determine the safety and tolerability of introducing FT1050 during the standard course of dual umbilical cord blood transplant and will also track HSC engraftment efficiencies and patient outcomes.

The Company's discovery engine utilizes the most advanced reprogramming technologies for generating cell types of interest to elucidate disease biology and identify targets for therapeutic intervention. Fate Therapeutics' protein-based reprogramming platform in combination with its novel small molecule conditions offers a highly efficient, non-viral, non-DNA based method to recapitulate human physiology for commercial scale drug discovery and therapeutic use. The Company has exclusively in-licensed from The Scripps Research Institute and the Whitehead Institute for Biomedical Research an intellectual property portfolio related to induced pluripotent stem cell (iPSC) technology, including filings that date back to November 2003. This portfolio includes the latest techniques published by Dr. Sheng Ding in October 2009, which use three small molecules to generate iPSCs in a manner that is 200 times more efficient than and twice as fast as conventional methods for reprogramming adult human cells.

"The Company is well-positioned to aggressively advance its leading iPSC technology platform for use in its own internal discovery programs as well as with strategic partners," said Scott Wolchko, chief financial officer of Fate Therapeutics. "With this Series B fina
'/>"/>

SOURCE Fate Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference
2. Esperion Therapeutics Initiates Phase I Clinical Study for ETC-1002
3. Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts, USA
4. Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer Therapeutics Conference
5. Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting
6. Nektar Therapeutics Reports Third Quarter 2009 Financial Results
7. Tolera Therapeutics Files IND Application for TOL101, Appoints OToole to Lead Clinical Operations
8. Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
9. Cell Therapeutics, Inc.s (CTI) Presentation at BIO Investor Forum to be Webcast
10. Oxygen Biotherapeutics, Inc. Expands Board of Directors
11. Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 BioTrends Research Group, one of ... specialized biopharmaceutical issues, finds that, unaided, one in ... reported that in the past six months, they ... in anticipation of the next generation of HCV ... only 6 percent reported that they had begun ...
(Date:5/23/2013)... Ill. , May 23, 2013 Z ... providing value-added ingredients to a variety of industries, announced ... in a panel discussion at this year,s National Restaurant ... 20-21, 2013, on behalf of the Research Chefs Association.  ... for Restaurants: The Good, the Bad and the Ugly," ...
(Date:5/23/2013)... The New Jersey chapter of the ... Processing Associates (BDPA), is hosting its 10th annual Families ... all-day event will encourage students and their parents to ... outs from many of the industries’ finest teachers. Held ... Jersey Institute of Technology, the event will include workshops, ...
(Date:5/23/2013)... 23, 2013  Verenium Corporation (Nasdaq: VRNM ... development and commercialization of high-performance enzymes, today announced that ... will present at two upcoming conferences. (Logo: ... at the Second Annual Marcum LLP Microcap Conference on ... in New York City.  The presentation is scheduled to ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3
... SANTA CLARA, Calif., Dec. 17 Once thought ... NVIDIA(R) GeForce(R) graphics,processing units (GPUs) with CUDA(TM) technology ... scientific computation. Berkeley,s Open Infrastructure,for Network Computing ... the world, is using CUDA technology to tap ...
... In a recent customer satisfaction,survey of over 30,000 ... voted by its customers as the "Top Of Class" ... pathologists who,subscribe to ADVANCE chose bioMerieux over other clinical ... support," "reliable,instruments," and "quick response time." , ...
... , , Acquisition will expand Abbott,s ... , CARLSBAD, Calif. and ABBOTT PARK, Ill., Dec. 17 ... (NYSE: ABT ) announced today that Abbott has exercised ... Inc., an Isis subsidiary, for a closing purchase price of $175 ...
Cached Biology Technology:NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 2NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 3NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 4NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 5NVIDIA CUDA Technology Dramatically Advances the Pace of Scientific Research 6Laboratory Customers Name bioMerieux 'Top Of Class' for Microbiology 2Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis 2Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis 3Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis 4Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis 5
(Date:5/24/2013)... largest and fastest growing open-access publishers, today announces the ... . , A broad scope journal covering all specialties, ... and interactive web platform for the research community to ... Frontiers, real-time and interactive peer-review enables fast, fair and ... an average of three months from submission to final ...
(Date:5/24/2013)... In recent years, microRNAs (miRNAs) and other non-coding ... expression of specific proteins. In recent years they ... been used to establish tissue origin for cancers ... responses and screen for disease, but clinically tractable, ... samples are not currently available. In this issue ...
(Date:5/24/2013)... scientists from around the world today issued a stark ... of one or two generations, the majority of the ... the handicap of severe pressure on fresh water, an ... substitute. This handicap will be self-inflicted and is, we ... chronic underlying problems led by mismanagement and sent a ...
Breaking Biology News(10 mins):Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4
... Data Sharing Consortium Now Includes over 40 Agencies ... (OTC Bulletin Board: BKYI), a leader in finger-based ... announced a contract award from the Tulsa County, ... mobile data solution. Using MobileCop on laptops in ...
... of the American Society of Civil Engineers (ASCE) has ... Schuring, Stabile Professor for Innovation and Technology at NJIT. ... Sheryl Weinstein at 973-596-3436.) Schuring, of Blairstown, ... years of experience in the areas of geotechnical and ...
... the oil tanker Exxon Valdez was exiting Alaska,s Prince William ... the night. What happened next is considered one of the ... spilled into the pristine Alaskan waters, eventually covering 11,000 square ... the amount of oil spilled in the Exxon Valdez accident. ...
Cached Biology News:Tulsa County Sheriff Selects BIO-key(R) Mobile Data System 2Civil engineers name NJIT's John Schuring Educator of Year 2UCSB scientists document fate of huge oil slicks from seeps at coal oil point 2UCSB scientists document fate of huge oil slicks from seeps at coal oil point 3UCSB scientists document fate of huge oil slicks from seeps at coal oil point 4
... reduce the chance of error. Thats the ... using Beckman Coulters extensive experience in laboratory ... the CEQ 8000 is a fully automated ... the capillary array with a patented linear ...
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
... The APO-BRDU Kit is a 2-color ... total cellular DNA to detect apoptotic cells ... instructions and reagents required for measuring apoptosis ... cells for assessing reagent performance; washing, reaction ...
... VISION Sytem is a highly advanced ... proprietary digital imaging and automation technology ... acquisition, analysis, archving/retrieval and colored professional ... digital imaging system that aids in ...
Biology Products: